CompletedPhase 4

Opioid Free Anesthesia and Bariatric Surgery

United States58 participantsStarted 2021-08-09

Plain-language summary

The morbidly obese bariatric surgery population is susceptible to opioid-induced complications such as respiratory depression and postoperative nausea and vomiting. This population may in particular benefit from opioid-sparing or opioid-free anesthetic techniques. This study aims to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ASA I-III * Non-pregnant * Undergoing laparoscopic bariatric surgery for weight loss. Exclusion Criteria: * Unable to obtain informed consent or consent withdrawn. * Patients who are pregnant or nursing. * ASA IV-V * Alcohol or narcotic misuse or dependence in the last 2 years. * Preoperative daily opioid use for one year for pain management. * Egg or soy product allergy * Active liver disease * Patients with left ventricular assist devices * Abnormal renal function * Any contraindication to any opioid or non-opioid pain analgesics * Any physical, mental or medical condition that in the opinion of the investigator, makes study participation inadvisable.

What they're measuring

Quality of Recovery

Timeframe: Up to two postoperative weeks

Trial details

NCT IDNCT04144153

SponsorNorthwell Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-01

View on ClinicalTrials.gov More Postoperative Quality of Recovery trials